Cleared Traditional

K952160 - INTRAVASCULAR (I-V) ADMININISTRATION SET (DVGENPERS FPA)

K952160 is an FDA 510(k) clearance for INTRAVASCULAR (I-V) ADMININISTRATION SE..., manufactured by Medex, Inc.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 136-day FDA review.

K952160 · Medex, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1995
Decision
136d
Days
Class 2
Risk

K952160 is an FDA 510(k) clearance for the INTRAVASCULAR (I-V) ADMININISTRATION SET (DVGENPERS FPA). Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Medex, Inc. (Dublin, US). The FDA issued a Cleared decision on September 21, 1995 after a review of 136 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Medex, Inc. devices

FDA 510(k) Submission Details - K952160

510(k) Number K952160 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 08, 1995
Decision Date September 21, 1995
Days to Decision 136 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
7d slower than avg
Panel avg: 129d · This submission: 136d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 773
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K952160.
LOW PROFILE SAFSITE Y-SITE
K954123 · B.Braun Medical, Inc. · Nov 1995
LIFESHIELD LUER ACTIVATED VALVE MALE ADAPTER PLUG
K953584 · Abbott Laboratories · Oct 1995
IVAC BALL VALCE ADMIN. SETS
K953225 · Y · Sep 1995
PLASTIC BLUNT CANNULA
K952976 · Marquette Medical, Inc. · Sep 1995
VENTED/NONVENTED GEMINI ADMINISTRATION SET WITH CHECK VALVE AND TWO SAFSITE(TM) VALVES
K950153 · Imed Corp. · Aug 1995
FIXED FLOW RATE GRAVITY ADMINISTRATION SETS
K952760 · I-Flow Corp. · Aug 1995